| Website | pearltherapeutics... |
| Category | BioTech |
| Phone | 650-305-2600 |
| Employees | |
| Description | Respiratory Disease research |
| Total | $102M |
| Series A, 7/08 Clarus Ventures New Leaf Venture Partners 5AM Ventures Nektar Therapeutics | $18M |
| Series C, 3/10 Clarus Ventures New Leaf Venture Partners 5AM Ventures | $15M |
| Series C, 10/10 Vatera Healthcare New Leaf Venture Partners 5AM Ventures | $69M |
Pearl is a privately held company led by a seasoned team of respiratory product development experts. Pearl’s goal is to create high quality therapies for better treatment and prevention of chronic respiratory diseases. Pearl’s products will offer patients and healthcare providers alternatives that better meet their needs and improve upon the safety and efficacy of existing respiratory therapeutics to achieve better clinical outcomes. nice goal.
